Pier Capital, LLC Avid Bioservices, Inc. Transaction History

Pier Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.63 - $21.55 $4,244 - $7,865	-365 Reduced 0.18%	200,203 $3.06 Million
Q1 2022 May 10, 2022	BUY	$16.63 - $27.73 $49,939 - $83,273	3,003 Added 1.52%	200,568 $4.09 Million
Q4 2021 Feb 10, 2022	SELL	$20.7 - $34.18 $3.39 Million - $5.6 Million	-163,722 Reduced 45.32%	197,565 $5.77 Million
Q3 2021 Nov 10, 2021	SELL	$19.05 - $28.32 $2.15 Million - $3.2 Million	-112,992 Reduced 23.82%	361,287 $7.79 Million
Q2 2021 Aug 12, 2021	SELL	$18.93 - $25.65 $2.27 Million - $3.07 Million	-119,658 Reduced 20.15%	474,279 $12.2 Million
Q1 2021 May 13, 2021	SELL	$11.86 - $21.77 $1.59 Million - $2.91 Million	-133,887 Reduced 18.4%	593,937 $10.8 Million
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $1.96 Million - $3.18 Million	270,714 Added 59.22%	727,824 $8.4 Million
Q3 2020 Nov 13, 2020	BUY	$6.53 - $8.6 $2.98 Million - $3.93 Million	457,110 New	457,110 $3.48 Million

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.